GSK Stock: How It’s Spending Up To $3.3 Billion To Square Off With Pfizer, Merck

GlaxoSmithKline (GSK) is squaring off with Pfizer (PFE) and Merck (MRK) after announcing Tuesday a $3.3 billion deal to buy pneumonia vaccine-maker Affinivax. But GSK stock dipped at the close. X The ...

Campbell Soup, Band Of Montreal, Royal Gold, Merck, Digital Realty

The Board of Directors of Campbell Soup today declared a regular quarterly dividend on Campbell’s capital stock of $0.37 per share. The quarterly dividend is payable Aug. 1, 2022 to shareholders...

Stocks Are Ready for a Bounce Higher After S&P 500 Closes Above Bear Market

Text size Dreamstime The stock market came awfully close to finishing Friday in a bear market, at least 20% off its peak in early January. Many investors would like to see it get there so Wall Street ...

Big Pharma Has Enough Cash to Buy All of Biotech. Why M&A Isn’t Happening.

Text size Late last year, Barron’s predicted a wave of deals, citing biotech companies’ cash holdings. Above, the plates used to print one-dollar bills. Alex Wong/Getty Images With biotech...

Chevron, Merck Lead Five Stocks Standing Tall In A Bad Market

Your stocks to watch for the week include five companies still doing well as the broader market falls: Dow Jones giants Chevron (CVX) and along with Merck (MRK), along with defense contractor Northrop...

Merck (MRK) earnings Q1 2022

Medicine pill is seen with Merck logo and words ‘Molnupiravir’ and ‘COVID-19’ displayed on a screen in the background in this illustration photo taken in Poland on November 5, ...

Six Dividend Stocks to Help Beat Inflation

The hot new investment theme isn’t socially nuanced crypto space finance or metaverse charging networks for virtual vehicles. It’s dividends—cash payments to shareholders. This year, U.S. equity divid...

AbbVie, Gilead and 4 Other Defensive Healthcare Stocks With Big Dividend Yields

Text size An AbbVie bio safety hood Courtesy of AbbVie Deep into the second quarter of the year, stocks have yet to recover, and investors are seeking safety in defensive plays. One sector that’s bene...

Here is how to trade Merck as it hovers at the $90 resistance level

Merck & Company (NYSE:MRK) closed last week at a valuation of $86.91. This was after opening the week at $88.32 and touching a high of $89.49. Merck faces notable resistance at $90. This resistanc...

Discovery, Merck, Carnival, Broadcom, and Other Stocks to Watch This Week

Text size Uncredited It’s a full week of annual shareholder meetings, investor days, and earnings reports. Broadcom hosts its annual meeting on Monday, followed by investor events from Merck, Analog D...

Discovery, Merck, Carnival, Broadcom, and Other Stocks for Investors to Watch This Week

Text size Uncredited It’s a full week of annual shareholder meetings, investor days, and earnings reports. Broadcom hosts its annual meeting on Monday, followed by investor events from Merck, Analog D...

WHO Backs Merck’s Antiviral Pill For High-Risk Covid Patients But Finds Regeneron’s Antibody Cocktail ‘Ineffective’ Against Omicron

Topline The World Health Organization has recommended Merck’s molnupiravir to treat high-risk Covid patients, the agency announced Thursday, the first oral antiviral it has endorsed though availabilit...

Merck’s Anti-Covid Pill Shows Better Effectiveness In Indian Study

Topline Merck and Ridgeback Biotherapeutics’ Covid-19 antiviral pill molnupiravir reduced the risk of hospitalization by over 65% in a clinical trial conducted by their Indian partner Hetero, the comp...

Merck (MRK) earnings Q4 2021

Merck sold $952 million of its Covid-19 treatment pill molnupiravir in the fourth quarter, saying Thursday it’s on track to sell another $5 billion to $6 billion more this year. Most of its sale...

Absci Corp up 50% after announcing research collaboration with Merck

Absci Corporation (NASDAQ: ABSI) went up 50% after it announced that it had executed a research and collaboration agreement with Merck, commonly referred to as MSD outside Canada and the US. The compa...

Intel Joins the Dogs of the Dow. Why These Stocks Could Be a Good Strategy This Year.

Text size Sign at Intel headquarters in Santa Clara, Calif. Intel joins the so-called Dogs of the Dow for 2022. David Paul Morris/Bloomberg Intel will join the Dogs of the Dow for 2022, replacing Cisc...